| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride Dihydrate |
| Available forms, composition and doses of Dom-Ondansetron: |
| Tablets; Oral; Ondansetron Hydrochloride Dihydrate 4 mgTablets; Oral; Ondansetron Hydrochloride Dihydrate 8 mg |
| Dom-Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Dominion Pharmacal |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Apo-Ondansetron | Ondansetron Hydrochloride Dihydrate | Apotex |
| Co Ondansetron | Ondansetron Hydrochloride Dihydrate | Cobalt Pharmaceuticals |
| Danac | Ondansetron Hydrochloride Dihydrate | Teva |
| Dantroxal | Ondansetron Hydrochloride Dihydrate | Sandoz |
| Domegan | Ondansetron Hydrochloride Dihydrate | Genfa Medica; Omega Laboratories |
| Dosartron | Ondansetron Hydrochloride Dihydrate | Landsteiner Scientific |
| Emistop | Ondansetron Hydrochloride Dihydrate | Claris Lifesciences; Macropharma Corporation |
| Gen-Ondansetron | Ondansetron Hydrochloride Dihydrate | Genpharm |
| Invomit | Ondansetron Hydrochloride Dihydrate | Interbat |
| Latran | Ondansetron Hydrochloride Dihydrate | Farmzaschita SPC |